Scantox performs both in-vivo and in-vitro tests according to GMP. The tests are potency or quality tests like bacterial endotoxins (LAL-test) and they are performed either after pharmacopeial methods or client specific methods. Scantox has performed GMP tests for a number of years and is regularly inspected by the Danish Medicines Agency.
Scantox is a GLP-accredited pre-clinical contract research organization originally founded in 1977. Since 2021 Scantox is owned by the Nordic based investment company Impilo. Our focus is on providing high quality work within pharmacology, toxicology and histopathology. We service both global and local partners and are considered world leading within minipig toxicology.
Scantox Group, Headquarters
Hestehavevej 36 A
DK- 4623 Lille Skensved
Denmark (CVR 83090413)
Scantox Sweden – Lund
Medicon Valley, Scheelevägen 2
223 63 Lund, Sweden
Scantox Sweden – Solna
Nobels Väg 16
171 65 Solna, Sweden
